The Company Outsmarting Big Pharma in Africa
Harvard Business Review
AUGUST 17, 2012
It has doubled its market cap in the five years and sales reached almost $1.5 What's more, these are markets that traditional developed market firms are increasingly targeting for their own growth goals. and other traditionally developed markets. and other traditionally developed markets.
11 
Let's personalize your content